Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,310,361
in 7 filings, $252K under 10b5-1 plans

Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-31 Hasnain Faheem Director Grant or award · Option to purchase common stock +26,000 26,000
2023-05-31 Collins Helen Louise Director Grant or award · Option to purchase common stock +26,000 26,000
2023-02-16 DOYLE THOMAS JAMES SVP, Finance & Accounting Grant or award +10,625 27,466
2023-02-16 DOYLE THOMAS JAMES SVP, Finance & Accounting Grant or award · Option to purchase common stock +63,750 63,750
2023-02-16 Bair Teresa Brophy Chief Legal Officer Grant or award +23,125 23,125
2023-02-16 Bair Teresa Brophy Chief Legal Officer Grant or award · Option to purchase common stock +138,750 138,750
2023-02-16 FORD KATHLEEN Chief Operating Officer Grant or award · Option to purchase common stock +185,000 185,000
2023-02-16 DALE STEPHEN Chief Medical Officer Grant or award +23,125 50,800
2023-02-16 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +185,000 185,000
2023-02-16 WILSON TROY EDWARD President and CEO Grant or award · Option to purchase common stock +560,000 560,000
2023-01-27 FORD KATHLEEN Chief Operating Officer Sale −1,821 $13.89 $25K 21,214
2023-01-27 FLOWERS KIRSTEN CCO & Chief Strategy Officer Sale −1,906 $13.89 $26K 20,605
2023-01-27 DOYLE THOMAS JAMES SVP, Finance & Accounting Sale −682 $13.89 $9K 17,707
2023-01-27 DOYLE THOMAS JAMES SVP, Finance & Accounting Sale −866 $13.89 $12K 16,841
2023-01-27 DALE STEPHEN Chief Medical Officer Sale −4,385 $13.89 $61K 32,515
2023-01-27 DALE STEPHEN Chief Medical Officer Sale −4,840 $13.87 $67K 27,675
2022-11-17 Bair Teresa Brophy Chief Legal Officer Sale −2,100 $15.22 $32K 0
2022-10-06 WILSON TROY EDWARD President and CEO Other disposition −1,084,300 8,394
2022-10-06 WILSON TROY EDWARD President and CEO Other acquisition +1,084,300 1,125,618
2022-08-19 WILSON TROY EDWARD President and CEO Other disposition −17,708 1,134,012

Page 10 of 19 · 366 trades